Adherence to a “Southern diet” may be the biggest driver of racial disparities in hypertension rates among black and white adults in the U.S., according to a prospective cohort study published Oct. 2 in JAMA.

The consequences of sexual harassment and assault—the former of which up to 81 percent of women say they’ve experienced at some point in their lifetime—aren’t just mental, according to a study presented at the North American Menopause Society symposium in San Diego. They’re also physical, putting women at a higher risk for hypertension and sleep disorders.

Metabolic parameters like body weight, blood pressure, cholesterol and blood sugar levels are established risk factors for cardiovascular disease. But a new study suggests it’s not just abnormal measures of these components that portend risk—significant fluctuations in these areas are independently linked to all-cause mortality, heart attack and stroke among otherwise healthy people.

An increased intake of vitamin B, paired with routine ACE inhibitor therapy, could help protect kidney function in kids and teens with type 1 diabetes (T1D), according to a study presented at the 57th annual European Society for Pediatric Endocrinology Meeting in Athens, Greece.

Biopharmaceutical company Amarin this week announced the topline results of its REDUCE-IT trial, a global study that achieved 25 percent cardiovascular risk reduction in a population of 8,179 statin-treated adults with the daily use of Vascepa, also known as icosapent ethyl.

SAN DIEGO — An endovascular ultrasound-based renal denervation (RDN) approach led to greater reductions in blood pressure than radiofrequency ablation in patients with resistant hypertension, according to the first randomized trial to compare the techniques.

A report published by charity organization Cancer Research U.K. suggests obesity is on track to eclipse smoking as the greatest cause of preventable cancer in British women—something experts say could happen by 2043, the Guardian has reported.

A recent meta-analysis published in Circulation: Cardiovascular Quality and Outcomes suggests the benefit of anticoagulation for pulmonary arterial hypertension (PAH) may depend on the subtype of the condition. Mortality rates improved with anticoagulation for patients with idiopathic PAH but worsened for those with scleroderma-associated PAH.